Detailed answers about EUPHROSYNE INVESTMENT LIMITED, including incorporation, status, business activity, and accounts information.
When was EUPHROSYNE INVESTMENT LIMITED founded?
EUPHROSYNE INVESTMENT LIMITED was officially incorporated on 5 January 2022 and is registered under company number 13831332. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is EUPHROSYNE INVESTMENT LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of EUPHROSYNE INVESTMENT LIMITED?
EUPHROSYNE INVESTMENT LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does EUPHROSYNE INVESTMENT LIMITED do?
EUPHROSYNE INVESTMENT LIMITED operates in the following sectors: 64304 - Activities of open-ended investment companies, 70100 - Activities of head offices. These SIC codes provide insight into the company's business activities and industry focus.
What is EUPHROSYNE INVESTMENT LIMITED's registered address?
The registered office address of EUPHROSYNE INVESTMENT LIMITED is FLAT 7 CLARENDON COURT, 34 GROVE STREET, OXFORD, ENGLAND, OX2 7JJ. This is the official address filed with Companies House for legal and statutory correspondence.
Is EUPHROSYNE INVESTMENT LIMITED financially stable?
The most recent accounts for EUPHROSYNE INVESTMENT LIMITED were made up to 31 January 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 October 2026.